Gao Yu-Fei, Liu Rong-Jun, Li Ya-Xin, Huang Chenmilu, Liu Yi-Yun, Hu Chen-Xi, Qi Hong
Department of Ophthalmology; Beijing Key Laboratory of Restoration of Damaged Ocular Nerve, Peking University Third Hospital, Beijing 100191, China.
The First Hospital of Fangshan District, Beijing 102400, China.
Int J Ophthalmol. 2019 Nov 18;12(11):1708-1713. doi: 10.18240/ijo.2019.11.07. eCollection 2019.
To compare the anti-inflammatory effects of intense pulsed light (IPL) with tobramycin/dexamethasone plus warm compress through clinical signs and cytokines in tears.
Eighty-two patients with dry eye disease (DED) associated meibomian gland dysfunction (MGD) were divided into two groups. Group A was treated with IPL, and Group B was treated with tobramycin/dexamethasone plus warm compress. Ocular Surface Disease Index (OSDI), tear film breakup time (TBUT), corneal fluorescein staining (CFS), meibomian gland expressibility (MGE), meibum quality, gland dropout and tear cytokine levels were evaluated before treatment, 1wk and 1mo after treatment.
TBUT in Group A was higher (=0.035), and MGE score was lower than Group B at 1mo (=0.001). The changes of interleukin (IL)-17A and IL-1β levels in tears were lower in Group A compared with that in Group B at 1wk after treatment (=0.05, =0.005).
Treatment with IPL can improve TBUT and MGE and downregulate levels of IL-17A and IL-1β in tears of patients with DED associated MGD better than treatment with tobramycin/dexamethasone plus warm compress in one-month treatment period.
通过临床体征和泪液中的细胞因子,比较强脉冲光(IPL)与妥布霉素/地塞米松联合热敷的抗炎效果。
82例伴有睑板腺功能障碍(MGD)的干眼疾病(DED)患者被分为两组。A组接受IPL治疗,B组接受妥布霉素/地塞米松联合热敷治疗。在治疗前、治疗后1周和1个月评估眼表疾病指数(OSDI)、泪膜破裂时间(TBUT)、角膜荧光素染色(CFS)、睑板腺可挤压性(MGE)、睑脂质量、腺体缺失情况和泪液细胞因子水平。
1个月时,A组的TBUT较高(=0.035),MGE评分低于B组(=0.001)。治疗后1周,A组泪液中白细胞介素(IL)-17A和IL-1β水平的变化低于B组(=0.05,=0.005)。
在为期1个月的治疗期内,与妥布霉素/地塞米松联合热敷治疗相比,IPL治疗能更好地改善DED合并MGD患者的TBUT和MGE,并下调其泪液中IL-17A和IL-1β的水平。